Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹1,012.55
38.40 (3.65%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹5.14K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
253.6
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹480+110.9%
52W High₹1,094-7.4%
Current Price
₹1,012.55
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹810.04
Upper Circuit₹1,215.06
Reference Price
₹1,012.55
Investment Checklist
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 59.23 (STRONG_BUY) with 51.8% confidence
3-day momentum: +9.5% — strong upward pressure
10/20 Bearish Cross detected 2 day(s) ago
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
52%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
955.56
EMA50
857
EMA200
755.28
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows6
Lower Highs5
Lower Lows3
Support & Resistance Levels
Resistance (Above)
₹1094.00
Support (Below)
₹917.50
₹899.00
₹875.70
₹816.25
₹801.94
Volume Analysis
TrendINCREASING
Change+96.90%
Unusual VolumeNo
Recent MA Crossovers
10/20 Bearish Cross
2 days ago
SELL
Stop Loss Levels
Fixed Risk
1% Risk₹1002.42
3% Risk₹982.17
5% Risk₹961.92
7% Risk (Custom)
₹941.67Technical Levels
1x ATR (Volatility)₹954.67
2x ATR (Swing)₹896.79
3x ATR (Trend)₹838.91
Immediate Support₹917.50
Moving Averages
EMA 9 (Short-term)₹987.01
EMA 20 (Medium-term)₹955.56
EMA 50 (Trend)₹857.00
EMA 200 (Long-term)₹755.28
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹229.5 Cr | ₹172.9 Cr | ₹193.5 Cr | ₹207.3 Cr |
| Net Profit | ₹22.3 Cr | ₹14.9 Cr | ₹-5.7 Cr | ₹-12.6 Cr |
| EPS | — | ₹2.94 | ₹-1.13 | ₹-2.49 |
| Operating Profit | ₹31.9 Cr | ₹25.6 Cr | ₹9.3 Cr | ₹6,07,000 |
ROE
7.86%
ROCE
7.64%
Debt/Equity
0.14
Current Ratio
2.83
OPM
0.03%
NPM
-6.09%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Orchid Pharma Limited | ₹1,012.55 | -3.65% | 253.6 | ₹5.14K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 02 Aug 2023 | Annual General Meeting | AGM |
| 22 Dec 2022 | Extra Ordinary General Meeting | OTHERS |
| 06 Jul 2022 | Annual General Meeting | AGM |
| 04 Aug 2021 | Annual General Meeting | AGM |
| 18 Jun 2021 | Extra Ordinary General Meeting | OTHERS |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ORCHPHARMA
View All
positive
Business Standard - Markets 3d ago
Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why
Pharma stock rally: Orchid Pharma, Hikal, Unichem Labs, IOL Chemicals, SPARC, RPG Life Sciences and Acutaas Chemicals surged up to 13% in Wednesday's trade.
ABGSECABSL10BANKABSLAMCABSLBANETFABSLLIQUIDABSLNN50ETABSLPSEACUTAASALIVUSBSLGOLDETFBSLNIFTYBSLSENETFGGSEC10ABSLHEALTHYHIKALIOLCPJFLLIFEJFL-REJGCHEMLUPINMOMENTUMNIFTYQLITYORCHPHARMARPGLIFESAILIFESILVERSOLARASPARCSUVENTECHChemicalsFinancial Services
NEWS
positive
Business Standard - Markets 3d ago
Orchid Pharma soars on Exblifep commercialization deal in Russia
Orchid Pharma surged 8.51% to Rs 1,005.50 after the company has entered into licensing and supply agreement with Pharmasyntez JSC (Pharmasyntez) to commercialize anitbotic, Exblifep in Russia.
ORCHPHARMAHealthcare
positive
CNBC TV18 - Markets 3d ago
Explained - Why this Smallcap Pharma stock jumped 13% for its best day in two years
Orchid's partnership with Pharmasyntez marks an important step in making Exblifep available to patients in Russia, according to Orchid Pharma Managing Director Manish Dhanuka.
DHANUKAORCHPHARMASMALLCAPChemicalsFinancial Services